Related Experiment Video
Updated: Jul 7, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Retrospective study of chemoradiotherapy based on cisplatin compared with radiotherapy alone for cervical cancer]
1Department of Gynecological Oncology, Beijing Obstetrics and Gynecology Hospital, Capital University of Medical Sciences, Beijing 100006, China.
Objective:
To compare the treatment effects and side events between chemoradiotherapy and radiotherapy alone for patients with primary cervical cancer.
Methods:
Totally 197 patients with primary cervical cancer in our hospital from 2000 to 2006 were studied. They were divided into two groups: radiotherapy alone (RT) or cisplatin-based chemoradiotherapy (CRT). Group of RT included 100 patients who received external irradiation by (60)Co and intracavitary irradiation by (192)Ir. Group of CRT included 97 patients who received cisplatin-based chemoradiotherapy. The RT regimen was the same as group RT.
Results:
The local control (CR + PR) in two groups had no statistic difference (P = 0.500). The total 5 year survival rate in the two groups were 82% and 79%, with no significant difference (P = 0.177); however, there was a significant difference for stage III squamous cell carcinoma of the cervix, the 5 year survival rate being 56% and 84%, respectively (P < 0.01). The common side effect was hematological toxicity in some patients, which was more serious in CRT group than in RT group. Grade 3 hematological toxicity were 3% and 14% (P < 0.01), although the long-term complications in two groups were not different (P = 0.496).
Conclusion:
Chemoradiotherapy based on cisplatin may be effective for stage III squamous cell carcinoma of the cervix.
